ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Pitt Cancer Center Director Herberman Issues “Precautionary Advice” On Cell Phone Use.

July 25, 2008

Afinitor Approved for Rare Disorder

November 5, 2010

NCI Supercomputer Operations To Start In April

November 15, 1985

In Brief: Salmon, Fidler Head ASCO, AACR; Durant, Pardee Presidents Elect; Namovicz, Other AOs Promoted

May 25, 1984

NCI To End CIS Partnership Program In 2010.

December 5, 2008

Appeals Court Finds Terminally Ill Patients Have Constitutional Right To Phase I Drugs.

May 5, 2006